What is gait?
the way a person walks
What is MS?
a chronic neurologic disease in which the bodys immune system damages its own nerve cells and connections between the brain and spinal cord
What is myelin?
a fatty protective layer that covers the axon fibers, that protects the nerves in the brain and spinal cord
Describe the pathophysiology of MS.
the triggers of MS are not fully understood, but a postulated theory is:
What are the risk factors for MS?
female sex (2-3x more likely)
viral infections (Epstein-Barr, measles, human herpes)
smoking
family history in 1st degree relative
changes in gut microbiome
obesity
variations in HLA genes
deficiencies of vitamin D
certain autoimmune diseases
Describe the clinical presentation of MS.
highly variable and patient-specific:
-vision issues (including possible vision loss)
-dizziness
-bladder and/or bowel dysfunction
-dyesthesias
-numbness and weakness of limbs
-ataxia
-neuropathic pain
-tremors
-Lhermittes Phenomenon
-Uhthoff Phenomenon
What might mimic symptoms of MS?
B12 deficiency
Which drugs are associated with an increased risk of MS?
TNF-alpha inhibitors
What are the 4 subtypes of MS?
clinically isolated syndrome
relapsing-remitting
secondary progressive
primary progressive
Describe CIS.
first episode of neurologic sx that lasts at least 24 hrs
pt reported sx that suggest MS w/o confirmed diagnosis
sx may include:
-unilateral optic neuritis, partial myelopathy, or focal syndromes
Describe RRMS.
consists of clearly defined worsening of sx, called relapses, followed by partial or full improvement of sx
relapses can last days to weeks
remission periods can last weeks to years
Which subtype of MS is most common?
RRMS
What is the goal of DMT?
keep pts in remission and to avoid relapses
-reduce relapses and delay progression of disease
Describe SPMS.
progressive course that follows RRMS
sx slowly worsen with variable remission and relapses
65% of pts convert 15-20 yrs after disease onset
Describe PPMS.
10-15% at onset
neurologic disability that steadily worsens from onset
no distinct periods of remission or relapse
diagnosis can only be made from disease hx
avg age of onset: 40 yrs old
What are the goals of therapy for MS?
reduce number, severity, and duration of relapses
slow disease progression
improve QoL
What is the cure for MS?
there is currently no cure for MS
What is the role for non-pharm measures in MS?
provide symptomatic improvement
What are the non-pharm measures for MS?
exercising:
-can improve balance, coordination, muscle tone, strength
avoid excessive heat or cold exposure
physiotherapy, massage, stretching:
-relief for spasticity and gait improvement
How do DMTs work?
reducing inflammation associated with relapse periods
In which subtypes of MS do DMTs have less utility?
PPMS and SPMS
Which therapy is approved for PPMS?
ocrelizumab
Which therapy is approved for SPMS?
siponimod
What are the 1st line DMTs?
interferon beta
glatiramer acetate
dimethyl fumarate
teriflunomide
siponimod
ozanimod
ponesimod
ocrelizumab (PPMS)